EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Care of Late‐Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries

Christopher Kruse iD, Anna Lipinski, Malte Verheyen, Monika Balzer-Geldsetzer, Michael Wittenberg, Stefan Lorenzl, Carmen Richinger, Christian Schmotz, Lars Tönges iD, Dirk Woitalla, Stephan Klebe, Bastiaan R Bloem und 14 weitere

Movement Disorders · 2024-03 · 39 (3) · 571-584

DOI: 10.1002/mds.29718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 29.02.2024. Verfasst von Christopher Kruse und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, Center for Translational Neuro- and Behavioral Sciences, University of Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Parkinsonian Disorders, Parkinson Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease (PD) is a neurodegenerative disease that leads to progressive disability. Cost studies have mainly explored the early stages of the disease, whereas late‐stage patients are underrepresented.

Objective

The aim is to evaluate the resource utilization and costs of PD management in people with late‐stage disease.

Methods

The Care of Late‐Stage Parkinsonism (CLaSP) study collected economic data from patients with late‐stage PD and their caregivers in five European countries (France, Germany, the Netherlands, UK, Sweden) in a range of different settings. Patients were eligible to be included if they were in Hoehn and Yahr stage >3 in the on state or Schwab and England stage at 50% or less. In total, 592 patients met the inclusion criteria and provided information on their resource utilization. Costs were calculated from a societal perspective for a 3‐month period. A least absolute shrinkage and selection operator approach was utilized to identify the most influential independent variables for explaining and predicting costs.

Results

During the 3‐month period, the costs were €20,573 (France), €19,959 (Germany), €18,319 (the Netherlands), €25,649 (Sweden), and €12,156 (UK). The main contributors across sites were formal care, hospitalization, and informal care. Gender, age, duration of the disease, Unified Parkinson's Disease Rating Scale 2, the EQ‐5D‐3L, and the Schwab and England Scale were identified as predictors of costs.

Conclusion

Costs in this cohort of individuals with late‐stage PD were substantially higher compared to previously published data on individuals living in earlier stages of the disease. Resource utilization in the individual sites differed in part considerably among these three parameters mentioned. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesParkinsonian DisordersParkinson DiseaseHumansEuropeGermany

Stichwörter der Autor:innen

Parkinson's diseasecost‐of‐illnesslate‐stage parkinsonismresource utilization

Autor:innen und Institutionen

  • Department of Geriatric Medicine, Center for Translational Neuro- and Behavioral Sciences, University of Duisburg-Essen, Essen, Germany.
  • Department of Neurology, Philipps-University Marburg, Marburg, Germany.
  • Coordination Center for Clinical Trials of the Philipps-University Marburg, Marburg, Germany.
  • Department of Palliative Medicine, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Institute of Palliative Care, Paracelsus Medical University, Salzburg, Austria.
  • Department of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, Germany.

ORCID-Profile: Christopher Kruse, Lars Tönges, Wassilios G Meissner, Kristina Rosqvist, Anette Schrag

Förderung

  • European Commission

Zitieren

APA

Kruse, C., Lipinski, A., Verheyen, M., Balzer-Geldsetzer, M., Wittenberg, M., Lorenzl, S., Richinger, C., Schmotz, C., Tönges, L., Woitalla, D., Klebe, S., Bloem, B. R., Hommel, A., Meissner, W. G., Laurens, B., Boraud, T., Foubert-Samier, A., Vergnet, S., Tison, F., …, & Dodel, R. (2024). Care of Late‐Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries. Movement Disorders, 39(3), 571-584. https://doi.org/10.1002/mds.29718

Vancouver

Kruse C, Lipinski A, Verheyen M, Balzer-Geldsetzer M, Wittenberg M, Lorenzl S, et al. Care of Late‐Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries. Movement Disorders. 2024;39(3):571-584. doi:10.1002/mds.29718

BibTeX
@article{Kruse2024,
  author = {Kruse, Christopher and Lipinski, Anna and Verheyen, Malte and Balzer-Geldsetzer, Monika and Wittenberg, Michael and Lorenzl, Stefan and Richinger, Carmen and Schmotz, Christian and Tönges, Lars and Woitalla, Dirk and Klebe, Stephan and Bloem, Bastiaan R and Hommel, Adrianus and Meissner, Wassilios G and Laurens, Brice and Boraud, Thomas and Foubert-Samier, Alexandra and Vergnet, Sylvain and Tison, François and Costa, Nadège and Odin, Per and Rosqvist, Kristina and Norlin, Jenny M and Hjalte, Frida and Schrag, Anette and Dodel, Richard},
  title = {Care of Late‐Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries},
  journal = {Movement Disorders},
  year = {2024},
  volume = {39},
  number = {3},
  pages = {571--584},
  doi = {10.1002/mds.29718}
}
Kostenlos starten →